Gelişmiş Arama

Basit öğe kaydını göster

dc.contributor.authorParlar, Kerem
dc.contributor.authorCakir, Mert
dc.contributor.authorOzer, Ozlem
dc.contributor.authorSharma, Prateek
dc.date.accessioned2025-10-06T06:29:27Z
dc.date.available2025-10-06T06:29:27Z
dc.date.issued2025
dc.identifier.issn2234-2443
dc.identifier.issn2234-2400
dc.identifier.urihttps://doi.org/10.5946/ce.2024.324
dc.identifier.urihttp://hdl.handle.net/11446/5436
dc.description.abstractBarrett’s esophagus is a premalignant precursor lesion of esophageal adenocarcinoma that affects approximately 1% of the population worldwide. Esophageal adenocarcinoma has a high mortality rate with a five-year survival of 15% to 20%. Early detection of Barrett's esophagus and dysplasia via endoscopy is crucial for preventing its progression to esophageal adenocarcinoma. New imaging techniques, such as image-enhanced endoscopy, have simplified the identification of Barrett’s esophagus, dysplasia, and esophageal adeno-carcinoma. Narrow-band imaging, blue-light imaging, and i-Scan are the prominent image-enhanced endoscopic techniques used to detect neoplasia. In Barrett’s screening and surveillance, key aspects such as the screening population, tools, and intervals need to be clearly defined and standardized for future guidelines to improve the detection of precursor lesions and reduce the incidence of esoph-ageal adenocarcinoma. Making image-enhanced endoscopy less subjective and enhancing the quality measures during endoscopy are crucial steps. Examples of quality measures include cleaning the esophagus before endoscopy and allowing sufficient time for inspection. Artificial intelligence systems can aid the early identification of lesions and reduce subjectivity. © 2025 Elsevier B.V., All rights reserved.en_US
dc.language.isoengen_US
dc.publisherKorean Society of Gastrointestinal Endoscopyen_US
dc.relation.ispartofClinical Endoscopyen_US
dc.identifier.doi10.5946/ce.2024.324
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectArtificial Intelligenceen_US
dc.subjectBarrett Esophagusen_US
dc.subjectEsophageal Neoplasmsen_US
dc.subjectImage-enhanced Endoscopyen_US
dc.subjectUpper Gastrointestinal Endoscopyen_US
dc.subjectArtificial Intelligenceen_US
dc.subjectBarrett Esophagusen_US
dc.subjectBlue Lighten_US
dc.subjectClinical Practice Guidelineen_US
dc.subjectDiagnosisen_US
dc.subjectEndoscopyen_US
dc.subjectEsophageal Adenocarcinomaen_US
dc.subjectEsophagusen_US
dc.subjectEsophagus Tumoren_US
dc.subjectGastrointestinal Endoscopyen_US
dc.subjectHumanen_US
dc.subjectMortality Rateen_US
dc.subjectNarrow Band Imagingen_US
dc.subjectPractice Guidelineen_US
dc.subjectReviewen_US
dc.titleFuture of image enhanced endoscopy of esophageal adenocarcinomaen_US
dc.typereviewen_US
dc.departmentDBÜen_US
dc.identifier.issue4en_US
dc.identifier.volume58en_US
dc.identifier.startpage503en_US
dc.identifier.endpage513en_US
dc.relation.publicationcategoryotheren_US
dc.department-tempParlar, Kerem, Department of Internal Medicine, İstanbul University-Cerrahpaşa Cerrahpaşa Faculty of Medicine, Istanbul, Turkey; Cakir, Mert, Department of Internal Medicine, Demiroglu Bilim University, Istanbul, Turkey; Ozer, Ozlem, Department of Internal Medicine, Demiroglu Bilim University, Istanbul, Turkey; Sharma, Prateek, Division of Gastroenterology and Hepatology, University of Kansas School of Medicine, Kansas City, United Statesen_US
dc.identifier.scopus2-s2.0-105013232507en_US
dc.identifier.scopusqualityQ2en_US
dc.snmzKA_Scopus_20251006
dc.indekslendigikaynakScopusen_US


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster